EMAIL THIS PAGE TO A FRIEND

The International journal of artificial organs

Time evolution of in vivo articular cartilage repair induced by bone marrow stimulation and scaffold implantation in rabbits.


PMID 25952995

Abstract

Tissue engineering techniques were used to study cartilage repair over a 12-month period in a rabbit model. A full-depth chondral defect along with subchondral bone injury were originated in the knee joint, where a biostable porous scaffold was implanted, synthesized of poly(ethyl acrylate-co-hydroxyethyl acrylate) copolymer. Morphological evolution of cartilage repair was studied 1 and 2 weeks, and 1, 3, and 12 months after implantation by histological techniques. The 3-month group was chosen to compare cartilage repair to an additional group where scaffolds were preseeded with allogeneic chondrocytes before implantation, and also to controls, who underwent the same surgery procedure, with no scaffold implantation. Neotissue growth was first observed in the deepest scaffold pores 1 week after implantation, which spread thereafter; 3 months later scaffold pores were filled mostly with cartilaginous tissue in superficial and middle zones, and with bone tissue adjacent to subchondral bone. Simultaneously, native chondrocytes at the edges of the defect started to proliferate 1 week after implantation; within a month those edges had grown centripetally and seemed to embed the scaffold, and after 3 months, hyaline-like cartilage was observed on the condylar surface. Preseeded scaffolds slightly improved tissue growth, although the quality of repair tissue was similar to non-preseeded scaffolds. Controls showed that fibrous cartilage was mainly filling the repair area 3 months after surgery. In the 12-month group, articular cartilage resembled the untreated surface. Scaffolds guided cartilaginous tissue growth in vivo, suggesting their importance in stress transmission to the cells for cartilage repair.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405515
Anti-CEACAM1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1400110
Anti-GCNT2 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB1410519
Anti-GCNT2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1407025
Anti-ST6GALNAC2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2701389
Anti-ST6GALNAC2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA048849
Anti-ST6GALNAC2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106801
Anti-TCN2 antibody produced in rabbit, affinity isolated antibody
SAB1406586
Anti-VIPR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4503084
Anti-VIPR1, C-Terminal antibody produced in rabbit, affinity isolated antibody
399396
Benzoin, purified by sublimation, ≥99.5%
C14H12O2
B8681
Benzoin, 98%
C14H12O2
WH0000634M1
Monoclonal Anti-CEACAM1 antibody produced in mouse, clone 2F10, purified immunoglobulin, buffered aqueous solution
SAB1403604
Monoclonal Anti-CEACAM1 antibody produced in mouse, clone 2F6, purified immunoglobulin, buffered aqueous solution
SAB1402938
Monoclonal Anti-TCN2 antibody produced in mouse, clone 2F4, purified immunoglobulin, buffered aqueous solution